Results overview: Found 1 records in 0.02 seconds.
Articles, 1 records found
Articles 1 records found  
1.
10 p, 1.9 MB High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy / Nuciforo, Paolo (Vall d'Hebron Institut d'Oncologia) ; Thyparambil, Sheeno (OncoPlex Diagnostics. USA) ; Aura, Claudia (Vall d'Hebron Institut d'Oncologia) ; Garrido-Castro, Ana (Hospital Universitari Vall d'Hebron) ; Vilaro, Marta (Vall d'Hebron Institut d'Oncologia) ; Peg, Vicente (Hospital Universitari Vall d'Hebron) ; Jimenez, José (Vall d'Hebron Institut d'Oncologia) ; Vicario, Rocío (Vall d'Hebron Institut d'Oncologia) ; Cecchi, Fabiola (OncoPlex Diagnostics. USA) ; Hoos, William (OncoPlex Diagnostics. USA) ; Burrows, Jon (OncoPlex Diagnostics. USA) ; Hembrough, Todd (OncoPlex Diagnostics. USA) ; Ferreres Piñas, Joan Carles (Hospital Universitari Vall d'Hebron) ; Pérez-Garcia, José (Hospital Universitari Vall d'Hebron) ; Arribas, Joaquín V. (Vicente) (Institució Catalana de Recerca i Estudis Avançats) ; Cortés, Javier (Hospital Universitari Vall d'Hebron) ; Scaltriti, Maurizio (Memorial Sloan Kettering Cancer Center) ; Universitat Autònoma de Barcelona
Introduction: Current methods to determine HER2 (human epidermal growth factor receptor 2) status are affected by reproducibility issues and do not reliably predict benefit from anti-HER2 therapy. Quantitative measurement of HER2 may more accurately identify breast cancer (BC) patients who will respond to anti-HER2 treatments. [...]
2016 - 10.1016/j.molonc.2015.09.002
Molecular Oncology, Vol. 10, núm 1 (January 2016) , p. 138-147  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.